Companies: 10,795·Total market cap: $144.5T
InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO.CNCNQHealthcare● Active
$3.40
$-0.20(-5.56%)
Market Cap$15295818
P/E Ratio—
52W High$21
52W Low$3.01
PE RatioMarket CapForecast

InnoCan Pharma Corporation (INNO.CN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

inno.cn · pe ratio · data through Jun 10, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
InnoCan Pharma Corporation
InnoCan Pharma CorporationYou
INNO.CN
$15MN/A——
BioNxt Solutions Inc.
BioNxt Solutions Inc.
BNXT.CN
$53MN/A—-$0.06
C21 Investments Inc.
C21 Investments Inc.
CXXI.CN
$48MN/A—-$0.03
Decibel Cannabis Company Inc.
Decibel Cannabis Company Inc.
DB.V
$66MN/A—-$0.01
iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc.
IAN.CN
$35MN/A—-$0.01
Leef Brands Inc.
Leef Brands Inc.
LEEF.CN
$45MN/A—-$0.15
Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc.
MDP.TO
$128M27.81x—$0.09

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for InnoCan Pharma Corporation (INNO.CN) measures how much investors pay for each dollar of the company's trailing earnings. INNO.CN's current PE ratio of N/A is calculated by dividing its stock price of $3.40 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $3.40 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

INNO.CN pe ratio · 6 questions

INNO.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $3.40 and TTM EPS of —. Data sourced from Financial Modeling Prep via INNO.CN's SEC 10-K and 10-Q filings.

INNO.CN PE ratioWhat is INNO.CN PE ratioCurrent PE ratio of INNO.CNINNO.CN PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · InnoCan Pharma Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10